Bergsdorf Christian, Kropp-Goerkis Carmen, Kaehler Irene, Ketscher Lars, Boemer Ulf, Parczyk Karsten, Bader Benjamin
Department of Screening, Lead Discovery Berlin, Bayer Schering Pharma AG, Berlin, Germany.
Assay Drug Dev Technol. 2008 Feb;6(1):39-53. doi: 10.1089/adt.2007.108.
Abstract: Compared to biochemical high-throughput screening (HTS) assays, cell-based functional assays are generally thought to be more time consuming and complex because of additional efforts for running continuous cell cultures as well as the numerous assay steps when transferring media and compounds. A common strategy to compensate the anticipated reduction in overall throughput is to implement highly automated cell culture and screening systems. However, such systems require substantial investments in sophisticated hardware and highly specialized personnel. In trying to set up alternatives to increasing throughput in functional cell-based screening, we combined several approaches. By using (1) cryopreserved cell aliquots instead of continuous cell culture, (2) cells in suspension instead of adherent cells, and (3) "ready-to-screen" assay plates with nanoliter aliquots of test compounds, an assay procedure was developed that very much resembles a standard biochemical, enzymatic assay comprising only a few dispense steps. Chinese hamster ovary cells stably overexpressing a Galphaq-coupled receptor were used as a model system to measure receptor activation by detection of intracellular D-myo-inositol 1-phosphate with the help of homogeneous time-resolved fluorescence (HTRF, CISbio International, Bagnols-sur-Cèze, France). Initially established in 384-well adherent cell format, the assay was successfully transferred to 1,536-well format. The assay quality was sufficient to run HTS campaigns in both formats with good Z'-factors and excellent reproducibility of antagonists. Subsequently, the assay procedure was optimized for usage of suspension cells. The influences of cell culture media, plate type, cell number, and incubation time were assessed. Finally, the suspension cell assay was applied to pharmacological characterization of a small molecule antagonist by Schild plot analysis. Our data demonstrate not only the application of the IP-One HTRF assay (CISbio International) for HTS in a high-density format, but furthermore the successful use of cryopreserved and suspension cells in a one-day functional cell-based assay.
与生化高通量筛选(HTS)分析相比,基于细胞的功能分析通常被认为更耗时且复杂,这是因为进行连续细胞培养需要额外的工作,以及在转移培养基和化合物时存在众多分析步骤。补偿预期的整体通量降低的一种常见策略是实施高度自动化的细胞培养和筛选系统。然而,此类系统需要在精密硬件和高度专业化人员方面进行大量投资。在尝试建立提高基于细胞的功能筛选通量的替代方法时,我们结合了多种方法。通过使用(1)冷冻保存的细胞等分试样而非连续细胞培养,(2)悬浮细胞而非贴壁细胞,以及(3)含有纳升等分试样测试化合物的“即筛即用”分析板,开发了一种分析程序,该程序非常类似于仅包含几个分配步骤的标准生化酶促分析。稳定过表达Gαq偶联受体的中国仓鼠卵巢细胞被用作模型系统,借助均相时间分辨荧光(HTRF,法国赛泽河畔巴尼奥勒的Cisbio International公司)检测细胞内D - 肌醇1 - 磷酸来测量受体激活。该分析最初以384孔贴壁细胞形式建立,随后成功转移至1536孔形式。两种形式的分析质量足以进行高通量筛选实验,具有良好的Z'因子和拮抗剂的出色重现性。随后,针对悬浮细胞的使用对分析程序进行了优化。评估了细胞培养基、板型、细胞数量和孵育时间的影响。最后,通过Schild图分析将悬浮细胞分析应用于小分子拮抗剂的药理学表征。我们的数据不仅证明了IP - One HTRF分析(Cisbio International公司)在高密度形式高通量筛选中的应用,而且还证明了冷冻保存和悬浮细胞在基于细胞的一日功能分析中的成功应用。